Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 5 mg - 230 EUR
  • 25 mg - 920 EUR
  • 100 mg - 2760 EUR

AC220

Quizartinib (AC220) is a small molecule receptor tyrosine kinase inhibitor that is currently under development for the treatment of acute myeloid leukaemia. Its molecular target is FLT3, also known as CD135, against which it has an IC50 of 0.56 nM.

catalogue number: A008
synonyms: Quizartinib
CAS: 950769-58-1
MW: 560.67 g/mol

References
Blood. 2009 Oct 1;114(14):2984-92. PMID: 19654408
J Med Chem. 2009 Dec 10;52(23):7808-16. PMID: 19754199